3rd Modern Drug Discovery & Development (M3D)

3rd Modern Drug Discovery & Development (M3D) Summit
http://www.gtcbio.com/conference/conferenceDetails.aspx?id=7
November 28-30, 2007 - San Francisco, CA

Agenda | Speakers List | Register

Dear Colleague,

Although the rate of productivity in the pharmaceutical industry has slowed due to hurdles and obstacles such as increased guidelines and higher safety standards, pharmaceutical and biotechnology companies are searching for new and innovative ways to expand their R&D pipeline and to bring drugs into the market faster and more efficiently.

With 6 full conferences, 6 study sessions, and 3 pre-conference workshops, the M3D Summit offers you a comprehensive look at the biopharmaceutical industry. The role of emerging markets in the pharmaceutical industry is changing and attending this summit will give you all the information you need to keep you abreast in your field.

Opening up the summit are 4 Plenary Keynote Presentations on:

"Discovery of the Nitric Oxide and Cyclic GMP Signaling Pathway and Application to Drug Development"
Nobel Laureate Ferid Murad, M.D., Ph.D., Professor; Director, Brown Inst. of Molecular Medicine, University of Texas Medical School

"Chorus, Lilly's Experiment in Early Phase Development"
Neil Bodick, Chief Operating Officer, Chorus, Eli Lilly & Co.

"Driving Global R&D Performance – Challenges & Opportunities"
Keith James, Vice President, Research Site Head, Pfizer La Jolla

"Cycle Time Reduction in Pre-Clinical Development-- A Key Driver in Boosting Productivity of R&D"
Mahdi Fawzi, Executive Vice President, Pre-Clinical Research, Wyeth Research

6 CONCURRENT TRACKS

• Biological Therapeutics
  Novel Therapeutics, Immunogenicity & Humanization, Alternative & Antibody Scaffolding, Strategies for Protein Therapeutic Stability, Alternative Therapeutics: Vaccines & RNAi
  

• Translational Medicine
  Target Identification, Target Validation, Maximizing Safety & Efficacy, Moving from Lab to Clinic, Human Plasma Proteome
  

• Drug Delivery Technology
  Oral Dosing, Pulmonary, Transmucosal, Transdermal, Combination Products, Approaches to Drug Solubization, Nano-Technology
  

• Drug Design & Lead Discovery
  Screening & Hit Identification, Hit to Lead, Lead Optimization, Data Management
  

• Emerging Targets
  Case Studies on Emerging Targets for 5 Major Disease Areas: Oncology, Metabolic Diseases, CNS Diseases, Inflammatory Pathways, Infectious Diseases
  

• Pharmaco - Kinetics, Dynamics, Genetics, & Genomics
  Pre-Clinical & Clinical Pharmacokinetics, Quantitative Aspects of PK/PD Modeling, Emerging Issues in Pharmacogenomics & Pharmacogenetics

6 STUDY SESSIONS

• Preparing Investigational New Drug Applications (INDs)

• Perturbing Signaling Pathways

• Salvaging Compounds from Drug Attrition

• Stem Cells as Tools for Drug Discovery

• Systems Biology: Breaking through the Complexity Barrier

• Predictive Toxicology and Safety

6 OPTIONAL WORKSHOPS

• Biotech & Pharmaceutical Licensing, Partnering & Deal-making

• Development and Implementation of Bioanalytical Methods Supporting Drug Disposition Studies for Small and Macromolecules

• Optimizing & Accelerating Clinical Research

For a full agenda visit: http://www.gtcbio.com/conference/m3d_agenda.aspx

Register 2, the 3rd goes free! Visit www.gtcbio.com for more information.
Click here to register.

If you have any questions or concerns, please do not hesitate to contact me.

Best regards,
Chris Brown

Chris Brown
Senior Conference Producer
GTCbio
434 W. Foothill Blvd.
Monrovia, CA 91016
T: 626-256-6405 ext. 102
F: 626-256-6460
E: chris.brown@gtcbio.com
W: www.gtcbio.com